new injectable biologic for moderate to severe plaque psoriasis called Stelara (stel-AR-a)

You'll soon hear about a new injectable biologic for moderate to severe plaque psoriasis called Stelara (stel-AR-a).

It's the first of a new class. It inhibits the inflammatory proteins interleukin-12 and -23...instead of tumor necrosis factor.

Some evidence suggests that Stelara might be more effective than Enbrel for psoriasis. But this isn't proven yet...and there are concerns about long-term safety.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote